Intercure (INCR) director discloses shares and stock options
Filing Impact
Filing Sentiment
Form Type
3
Rhea-AI Filing Summary
Intercure Ltd. director Michelson Lennie Grinbaum filed a Form 3 reporting his initial ownership in the company. He holds 6,743 Ordinary Shares directly, along with two blocks of stock options over additional Ordinary Shares.
These include options over 4,406 Ordinary Shares with a converted exercise price of $8.22 per share, granted on January 9, 2020 and fully vested as of January 9, 2023, expiring on January 9, 2030. He also holds options over 15,000 Ordinary Shares with a converted exercise price of $3.10 per share, granted on September 5, 2024, vesting quarterly over four years and expiring on September 5, 2028.
Positive
- None.
Negative
- None.
Insider Trade Summary
3 transactions reported
Mixed
3 txns
Insider
Michelson Lennie Grinbaum
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Share options (right to buy) | -- | -- | -- |
| holding | Share options (right to buy) | -- | -- | -- |
| holding | Ordinary Shares | -- | -- | -- |
Holdings After Transaction:
Share options (right to buy) — 4,406 shares (Direct, null);
Ordinary Shares — 6,743 shares (Direct, null)
Footnotes (1)
- The options were granted on January 9, 2020, and the current exercise price is NIS 25.146 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $8.22 per share. The options became fully vested as of January 9, 2023. The options were granted on September 5, 2024, and the current exercise price is NIS 9.50 per share. For purposes of this Form 3, the exercise price has been converted into U.S. dollars using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026, resulting in an exercise price of $3.1 per share. The options vest quarterly over four years from the date of grant.
Key Figures
Direct Ordinary Shares: 6,743 shares
Options at $3.10: 15,000 shares
Options at $8.22: 4,406 shares
+3 more
6 metrics
Direct Ordinary Shares
6,743 shares
Ordinary Shares held directly following Form 3
Options at $3.10
15,000 shares
Share options (right to buy) with $3.10 exercise price, expiring September 5, 2028
Options at $8.22
4,406 shares
Share options (right to buy) with $8.22 exercise price, expiring January 9, 2030
NIS to USD rate
3.06 NIS per $1.00
Exchange rate used to convert option exercise prices as of April 14, 2026
Original NIS price (2020 grant)
NIS 25.146/share
Exercise price before conversion for options granted January 9, 2020
Original NIS price (2024 grant)
NIS 9.50/share
Exercise price before conversion for options granted September 5, 2024
Key Terms
Share options (right to buy), exercise price, vested, Form 3, +1 more
5 terms
exercise price financial
"resulting in an exercise price of $8.22 per share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
vested financial
"The options became fully vested as of January 9, 2023"
Form 3 regulatory
"For purposes of this Form 3, the exercise price has been converted"
Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.
FAQ
What does Michelson Lennie Grinbaum report owning in Intercure (INCR) on this Form 3?
He reports direct ownership of 6,743 Ordinary Shares of Intercure Ltd. He also discloses two stock option grants over additional Ordinary Shares, giving him rights to acquire more shares at preset exercise prices if he chooses to exercise them.
How many Intercure (INCR) stock options does Grinbaum hold and at what exercise prices?
He holds options over 15,000 Ordinary Shares at a converted exercise price of $3.10 per share and options over 4,406 Ordinary Shares at a converted exercise price of $8.22 per share, reflecting different grant dates and terms for each option award.
When do Michelson Lennie Grinbaum’s Intercure (INCR) stock options vest and expire?
Options over 4,406 shares were granted January 9, 2020, became fully vested by January 9, 2023, and expire January 9, 2030. Options over 15,000 shares were granted September 5, 2024, vest quarterly over four years and expire September 5, 2028, if not exercised earlier.
Does this Intercure (INCR) Form 3 show any recent buying or selling by Grinbaum?
No specific purchases or sales are indicated; the entries are reported as holdings with unknown transaction codes. Form 3 primarily discloses his existing beneficial ownership position, rather than documenting new open‑market transactions in the company’s securities.
How were the exercise prices on Intercure (INCR) options converted in this Form 3?
Exercise prices originally set in Israeli shekels were converted using an exchange rate of NIS 3.06 to USD $1.00 as of April 14, 2026. This produced U.S. dollar exercise prices of $8.22 and $3.10 per share for the respective option grants.